SCHEMBL19989642

SCHEMBL19989642

CC(C)(C)OC(=O)N1CC=C(c2ccc(C=O)c(F)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.52
GRM1 Q13255 10/20 0.49
GRM5 P41594 9/20 0.49
PDK4 Q16654 1/20 0.47
TLR7 Q9NYK1 1/20 0.47
CDK7 P50613 1/20 0.45
CDK13 Q14004 1/20 0.45
CDK12 Q9NYV4 1/20 0.45
SOS1 Q07889 1/20 0.44
LIPC P11150 1/20 0.44
LIPG Q9Y5X9 1/20 0.44
CYP11B2 P19099 1/20 0.43
QDPR P09417 1/20 0.43
BRD4 O60885 1/20 0.42
CDK9 P50750 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29756644 1.00 NAMPT (0.52) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL20001500 0.90 NAMPT (0.42) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL29756646 0.89 NAMPT (0.49) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL19989715 0.89 NAMPT (0.49) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL6366609 0.88 NAMPT (0.56) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL31174297 0.88 NAMPT (0.56) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL24309522 0.85 NAMPT (0.54) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL29566866 0.85 NAMPT (0.54) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL15178435 0.85 NAMPT (0.54) NAMPTGRM1GRM5PDK4TLR7
SCHEMBL1198658 0.84 NAMPT (0.53) NAMPTGRM1GRM5PDK4TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3519387-B1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG A ST CO LTD (KR) 2021-08-11 EP disclosed
EP-3519387-B1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG A ST CO LTD (KR) 2021-08-11 EP disclosed
EP-3519387-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Dong-A ST Co., Ltd. (KR) 2019-08-07 EP disclosed
US-10160724-B2 Tetrahydropyridine derivatives and their use as antibacterial agents DONG-A ST CO., LTD. (KR) 2018-12-25 US disclosed
WO-2018062924-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-04-05 WO disclosed
WO-2018062924-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-04-05 WO disclosed
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-03-29 US disclosed
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-03-29 US disclosed
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS GALE, UGDH, PGLS NAMPT 94/4885GRM1 1124/4885GRM5 1014/4885
US-10160724-B2 Tetrahydropyridine derivatives and their use as antibacterial agents GALE, UGDH, PGLS NAMPT 94/4885GRM1 1124/4885GRM5 1014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.